Target intelligence / Profile preview

Biological membrane lipids and lipid peroxyl radicals (LOO•)

Target
LOO•
Molecular classification
Lipid, Reactive oxygen species, Free radical intermediate
01

Overview

Biological membrane lipids, particularly polyunsaturated fatty acids (PUFAs), are fundamental components of cellular and organelle membranes, providing structural integrity and regulating fluidity (Ayala et al., 2014, PMID: 24938831). Lipid peroxyl radicals (LOO•) are highly reactive chemical intermediates generated during lipid peroxidation, a self-sustaining free radical chain reaction often initiated by reactive oxygen species or iron-mediated catalysis (Niki, 2014, PMID: 24629910). The uncontrolled production of these radicals leads to the degradation of membrane phospholipids, the formation of toxic secondary products like malondialdehyde, and the induction of ferroptosis, a distinct form of regulated cell death (Dixon et al., 2012, PMID: 22579052). Consequently, these lipids and their radical derivatives are major therapeutic targets in diseases driven by oxidative damage, including Alzheimer's disease, atherosclerosis, and various forms of organ ischemia (Gaschler & Stockwell, 2017, PMID: 28213273). Pharmacological strategies focus on chain-breaking antioxidants and ferroptosis inhibitors, such as Vitamin E or Ferrostatin-1, which scavenge peroxyl radicals to halt the peroxidation process and protect cell viability (Niki, 2014, PMID: 24629910).

Other names
Lipid peroxidesMembrane phospholipidsPolyunsaturated fatty acidsPUFAsLipid hydroperoxidesLipid radicals
02

Mechanism of action

Chain-breaking antioxidant activity where the drug reacts with lipid peroxyl radicals to form stable products, thereby terminating the lipid peroxidation chain reaction (Niki, 2014, PMID: 24629910).

03

Biological functions

Membrane structural integrityCell signalingFerroptosis regulationOxidative stress mediation
04

Disease associations

Neurodegenerative diseaseCardiovascular diseaseCancerIschemia-reperfusion injuryAtherosclerosisInflammation
05

Safety considerations

Interference with physiological redox signalingPotential pro-oxidant effects at high concentrationsPoor bioavailability of lipophilic antioxidant compoundsOff-target effects on essential lipid metabolism
06

Interacting drugs

Alpha-tocopherol (Vitamin E)

6 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)4-Hydroxynonenal (4-HNE)F2-isoprostanes8-iso-PGF2alpha

Beyond the preview

Go deeper on Biological membrane lipids and lipid peroxyl radicals (LOO•).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biological membrane lipids and lipid peroxyl radicals (LOO•).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call